Skip to main content
Log in

Measurement of [18F]-fluorodeoxyglucose incorporation into human osteoblast–An experimental method

  • Brief Report
  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

An evaluation of human osteoblast metabolism usually involves measurements of the by-products of bone matrix elaboration. The assessment of glycolytic activity of osteoblasts is not a standard tool in most of the reports, but might be of value by providing a direct indicator of cellular metabolism. Measurement of the incorporation of [18F]-fluorodeoxyglucose, which is not further degradable following its conversion into glycose-6-phosphate during glycolysis and is trapped in this form within the cells, can be used as an effective research tool for estimation of osteoblast metabolism. In order to estimate the [18F]-fluorodeoxyglucose incorporation we used cultured human osteoblast-like cells. Following incubation of the culture samples in a glucose free medium with 5 μ Ci [18F]-fluorodeoxyglucose we measured the radioactivity of the cell fraction, as a percent from the initial dose, and compared to the incorporation values in cells treated by protoporphyrine IX (10−5 M), an endogenous pro-apoptotic agent. To compare the response of [18F]-fluorodeoxyglucose incorporation studies, following treatment of cells with the protoporphyrine IX, to other experimental cell metabolism evaluation methods, we performed a parallel comparison of alkaline phospatase activity, which is a standard measurement tool of osteoblast metabolism, in the control and treatment groups. A narrow range of 0.22–1.36% of [18F]-fluorodeoxyglucose incorporation per million cells was found. Additionally in the protoporphyrine IX treated cells a significant 62% decrease of [18F]-fluorodeoxyglucose incorporation was observed (p < .05). A parallel significant decrease in alkaline phosphatase activity (p < .001) was found in the cells treated by the protoporphyrine IX. Therefore we suggest that the presented method of [18F]-fluorodeoxyglucose incorporation measurement can be utilized as an effective research tool for estimation of the cellular glycolitic activity in human osteoblast-like cells in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  • Azarashvilli T, Grachev D, Krestinina O, Evtodienko Y, Yurkov I, Papadopoulos V, Reiser G (2007) The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria. Cell Calcium (in press)

  • Bessey OA, Lowry OH, Brock MJ (1946) A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 164:321–329

    CAS  Google Scholar 

  • Bouillin R (1990) Diabetic bone disease. Calcif Tissue Int 49:155–160

    Article  Google Scholar 

  • Bourke GJ, Daly LE, McGilvray J (1985) Interpretation and Uses of Medical Statistics. Third Edition, Blackwell Scientific Publication: 296–297

  • Brock CS, Meikle SR, Price P (1997) Does fluorine–18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology. Eur J Nucl Med 24:691–705

    PubMed  CAS  Google Scholar 

  • Golshani-Hebroni SG, Bessman SP (1997) Hexokinase binding to mitochondria: a basis for proliferative energy metabolism. J Bioenerg Biomembr 29:331–338

    Article  PubMed  CAS  Google Scholar 

  • Gundle R, Stewart K, Screen J, Beresford JN (1998) Isolation and culture of human bone-derived cells. In: Beresford N, Owen ME (eds) Marrow stromal cell culture. Cambridge university press, Cambridge, UK, pp. 43–66

    Google Scholar 

  • Haberkorn U, Morr I, Oberdorfer F, Bellemann ME, Blatter J, Altmann A, Kahn B, van Kaick G (1994) Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine. J Nucl Med 35:1842–1850

    PubMed  CAS  Google Scholar 

  • Levy JR, Murray E, Manolagas S, Olefsky JM (1986) Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells. Endocrinology 119:1786–1792

    Article  PubMed  CAS  Google Scholar 

  • Macmahon D (2006) Half-life evaluations for (3)H, (90)Sr, and (90)Y. Appl Radiat Isot 64:1417–1419

    Article  PubMed  CAS  Google Scholar 

  • Pauwels EKJ (2000) Positron-emission tomography with [18F]-fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 126:549–559

    Article  PubMed  CAS  Google Scholar 

  • Siffert RS (1951) The role of alkaline phosphatase in osteogenesis. J Exp Med 93:415–425

    Article  PubMed  CAS  Google Scholar 

  • Slosman DO, Pittet N, Donath A, Polla BS (1993) Fluorodeoxyglucose cell incorporation as an index of cell proliferation: evaluation of accuracy in cell culture. Eur J Nucl Med 20:1084–1088

    Article  PubMed  CAS  Google Scholar 

  • Thomas DM, Rogers SD, Sleeman MW, Pasquini GM, Brinqhurst FR, Nq KW, Zajac JD, Best JD (1995) Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01 a clonal osteogenic sarcoma cell line. J Mol Endocrinol 14:263–275

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nahum Rosenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenberg, N., Bettman, L., Rosenberg, O. et al. Measurement of [18F]-fluorodeoxyglucose incorporation into human osteoblast–An experimental method. Cytotechnology 54, 1–4 (2007). https://doi.org/10.1007/s10616-007-9066-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10616-007-9066-3

Keywords

Navigation